About
Eventus Diagnostics is an emerging life sciences company developing accurate and cost-effective blood tests that measure cancer-specific autoantibodies. The company's first products, the Octava Pink and Octava Blue tests, provide information that enables women and their physicians to better assess the validity of their mammography screening results for the improved diagnosis of breast cancer. The Octava Pink test is designed to provide additional diagnostic information to help physicians confirm true negative mammography findings with high accuracy, while helping to identify the presence of cancer in cases where mammography produces a false negative result and cancer is actually present. The Octava Blue test is designed for use in conjunction with screening mammograms to provide additional diagnostic information to help physicians confirm true abnormal mammography results with high accuracy, while also helping to reduce the large number of unnecessary biopsies caused by false alarms. Octava Blue has the potential to help reduce the number of unneeded biopsies by at least 50%, saving many women the anxiety and invasiveness of the biopsy procedure while also reducing unnecessary medical costs.
Funding history · 1 round · $2.7M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Eventus Diagnostics' primary focus?
- Eventus Diagnostics is a life sciences company developing accurate and cost-effective blood tests that measure cancer-specific autoantibodies, primarily for breast cancer diagnosis.
- What are the names of Eventus Diagnostics' initial products?
- Eventus Diagnostics' first products are the Octava Pink and Octava Blue tests.
- What is the purpose of the Octava Pink test developed by Eventus Diagnostics?
- The Octava Pink test is designed to provide additional diagnostic information to help physicians confirm true negative mammography findings and identify cancer in cases of false negative mammography results.
- What is the intended use of Eventus Diagnostics' Octava Blue test?
- The Octava Blue test is designed for use with screening mammograms to confirm true abnormal mammography results and potentially reduce unnecessary biopsies by at least 50%.
- When was Eventus Diagnostics founded?
- Eventus Diagnostics was founded in June 2010.
- What is the current operational status of Eventus Diagnostics?
- Eventus Diagnostics has been inactive since October 2016.
- How much funding has Eventus Diagnostics raised in total?
- Eventus Diagnostics has raised a total of $2,720,000 in funding. For a full financing history, please refer to startupim.
- When did Eventus Diagnostics complete its last known funding round?
- Eventus Diagnostics completed an undisclosed funding round in April 2014, raising $2,720,000.
- What is the employee count for Eventus Diagnostics?
- Eventus Diagnostics has an employee count in the range of 11-50, with an exact count of 31 employees.